The European Commission (EC) has granted marketing authorization for Inlyta (axitinib) from Pfizer for the treatment of adult patients with...
Astellas Pharma Europe has filed EC 905 its fixed dose combination of Flomaxtra XL (tamsulosin) and Vesicare(solifenacin)in the Netherlands under...
Sandoz, announces that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab), developed and registered by Samsung Bioepis
AstraZeneca announced that the European Commission (EC) has on 6 December 2013 granted Marketing Authorisation to Fluenz Tetra. Fluenz Tetra...
The European Commission (EC) has granted marketing authorization for Envarsus (tacrolimus once daily), from Veloxis Pharmaceuticals, for the prevention of...
UCB, a global biopharmaceutical company, announced that the European Commission (EC) has granted marketing authorization for Bimzelx (bimekizumab) for the treatment of active moderate to severe hidradenitis suppurativa (HS) in adults with an inadequate response to conventional systemic HS therapy
Retrophin, Inc. announced that the FDA has approved 100 mg and 300 mg tablets of Thiola EC (tiopronin), a new...
The European Commission has approved amendment of product information for Erbitux (cetuximab), from Merck Serono, updating the indication to the...
Amgen and Allergan plc . announced that the European Commission (EC) has granted marketing authorization for MVASI (biosimilar bevacizumab). MVASI...
The European Commission has granted marketing authorisation for Cervarix [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant], from Glaxo...